A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients

Douglass A. Morrison, Gulshan Sethi, Jerome Sacks, Frederick Grover, Steven Sedlis, Rick Esposito, K. B. Ramanathan, Darryl Weiman, Mitchell Krucoff, Francis Duhaylongsod, Thomas Raya, Stuart Pett, Sarah Vernon, Valdimir Birjiniuk, David Booth, Clive Robinson, J. David Talley, Tamim Antckli, Edward Murphy, Harkness FlotenVladimir Curcovic, John C. Lucke, Dan Lewis, Charles Barbiere, William Henderson

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

This multicenter, prospective randomized trial was designed to test the hypotheses that percutaneous coronary intervention (PCI) is a safe and effective alternative to coronary artery bypass grafting (CABG) for patients with refractory ischemia and high risk of adverse outcomes. As a comparison of revascularization strategies, the trial specifically allows surgeons and interventionists to use new techniques as they become clinically available. After 42 months of this 72-month trial, 17,624 patients have been screened and 2022 met eligibility requirements: 341 have been randomized to either CABG or PCI, and the remaining 1681 are being prospectively followed in a registry. The 3-year overall survival of patients in the registry and randomized trial is comparable. To enhance accrual into the randomized trial, site visits were conducted, a few low-accruing hospitals were put on probation and/or replaced, eligibility criteria were reviewed at annual meetings of investigators, and the accrual period was extended by 1 year. These data demonstrate that a prospective randomized trial and registry of coronary revascularization for medically refractory high-risk patients is feasible.

Original languageEnglish (US)
Pages (from-to)601-619
Number of pages19
JournalControlled Clinical Trials
Volume20
Issue number6
DOIs
StatePublished - Dec 1999
Externally publishedYes

Keywords

  • Angina
  • Angioplasty
  • Bypass
  • Coronary disease
  • Revascularization

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients'. Together they form a unique fingerprint.

Cite this